NEW YORK, July 27 (GenomeWeb News) - Geospiza and OpGen have secured a six-month, $100,000 Phase I Small Business Innovative Research grant from the National Institutes of Health to co-develop genomic sequencing tools based on optical mapping technology, the companies said today.
OpGen and Geospiza said they will use the funding to incorporate the output of optical mapping-based sequencing as input to the Phrap sequence assembly program.
OpGen is developing a sequencing method based on optical mapping, a single-molecule DNA analysis technology that the company claims can eventually be used to sequence whole genomes in minutes.
Geospiza said that the collaboration is in line with its ongoing effort to bring Phrap "up to date for modern assembly needs." In 2002, the company was awarded a $1.1 million SBIR to re-engineer Phrap for this purpose, which the company said will provide "a solid foundation" for the so-called "Optical-Map Phrap" application.